Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
äŒæ¥ã³ãŒãPLRZ
äŒç€ŸåPolyrizon Ltd
äžå Žæ¥Oct 29, 2024
æé«çµå¶è²¬ä»»è
ãCEOãIzraeli (Tomer)
åŸæ¥å¡æ°1
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 29
æ¬ç€Ÿæåšå°HaTidhar St. 5
éœåžRA'ANANA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·- -
é»è©±çªå·97293740120
ãŠã§ããµã€ãhttps://polyrizon-biotech.com/
äŒæ¥ã³ãŒãPLRZ
äžå Žæ¥Oct 29, 2024
æé«çµå¶è²¬ä»»è
ãCEOãIzraeli (Tomer)